AI Insight: Equifax's current price sits 7.8% below its fair value estimate of $189.19, indicating potential undervaluation amid valuation method disparities ranging from $97.45 to $383.95. Financial health scores reflect solid profitability but weak growth and liquidity, raising operational risk. High Monte Carlo volatility and 72.2% downside risk highlight significant price uncertainty despite upside potential.